跳至主要内容
临床试验/ACTRN12619000795190
ACTRN12619000795190已完成4 期

Randomised Controlled Non-Inferiority Trial: Microdrop Administration of Phenylephrine and Cyclopentolate Eye Drops in Neonates

niversity of Otago0 个研究点目标入组 150 人开始时间: 2019年5月30日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Blinded (masking used)

入排标准

年龄范围
6 Weeks 至 4 Months(—)
性别
All

入选标准

  • Premature neonates admitted to Invercargill, Dunedin, Christchurch, Wellington or Auckland City hospital’s neonatal intensive care units, who are undergoing routine ROPEE in accordance with the National Guidelines (e.g. infants born less than 31 weeks gestational age and/or less than 1250g birthweight).

排除标准

  • Neonates with, a) retinopathy of prematurity (ROP) greater than stage 2, b) current eye infection, c) not able to use phenylephrine or cyclopentolate eye drops.

研究者

相似试验